title: Respiratory syncytial virus immune globulin intravenous (human) receives marketing approval in Canada.
authors.affiliation: Dalhousie University.
authors.forename: J M
authors.initials: JM
authors.lastname: Langley
mesh_terms: D002170:Canada; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000191:economics / Q000627:therapeutic use*; D018357:Respiratory Syncytial Virus Infections / Q000628:therapy*; D018113:Respiratory Syncytial Virus, Human / Q000276:immunology*; D014481:United States
chemical_list: D016756:Immunoglobulins, Intravenous; C098685:respiratory syncytial virus immune globulin intravenous